Heartflow Inc
HTFL
查看詳細走勢圖
27.740USD
+1.750+6.73%
收盤 02/06, 16:00（美東）報價延遲15分鐘
2.32B總市值
虧損本益比TTM
盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
+6.73%
5天
-7.13%
1月
-17.12%
6月
-3.51%
今年開始到現在
-4.84%
1年
0.00%
查看詳細走勢圖
TradingKey Heartflow Inc股票評分
單位: USD 更新時間: 2026-02-06操作建議
Heartflow Inc當前公司基本面數據相對非常健康，最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理，在醫療設備與耗材行業排名129/205位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為38.50。中期看，股價處於下降通道。近一個月，市場表現非常差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Heartflow Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看空
Heartflow Inc亮點
亮點風險
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
估值高估
公司最新PE估值-5.69，處於3年歷史高位
先鋒集團持倉
明星投資者先鋒集團持倉，最新持倉1.57M股
分析師目標
基於
6
分析師
買入
評級
38.500
目標均價
+38.79%
漲幅空間
數據免責聲明：分析師評級與目標價由LSEG提供，僅供參考，不應當作投資建議
Heartflow Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Heartflow Inc簡介
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
公司代碼HTFL
公司Heartflow Inc
CEOFarquhar (John C. M)
網址https://www.heartflow.com/
相關品種
+2.98%
+0.07%
+1.61%
+2.48%
+0.31%
-1.14%
-0.06%
-2.37%
-1.78%
+2.58%
+2.59%
+2.02%
+1.93%
+2.38%
+1.74%
+0.16%
+0.75%
+1.72%
+0.57%
-2.02%熱門品種
